4-Bromo-2-ethylbenzenesulfonyl chloride → 4-Bromo-2-ethyl-N-((1-methyl-1H-indazol-5-yl)methyl)benzenesulfonamide
Reaction equation
[CH3:1][N:2]1[C:10]2[C:5](=[CH:6][C:7]([CH2:11][NH2:12])=[CH:8][CH:9]=2)[CH:4]=[N:3]1.[Br:13][C:14]1[CH:19]=[CH:18][C:17]([S:20](Cl)(=[O:22])=[O:21])=[C:16]([CH2:24][CH3:25])[CH:15]=1>>[Br:13][C:14]1[CH:19]=[CH:18][C:17]([S:20]([NH:12][CH2:11][C:7]2[CH:6]=[C:5]3[C:10](=[CH:9][CH:8]=2)[N:2]([CH3:1])[N:3]=[CH:4]3)(=[O:22])=[O:21])=[C:16]([CH2:24][CH3:25])[CH:15]=1Participants
3
Procedure
The titled compound was prepared according to the procedure described in step-1 of Example 1 from (1-methyl-1H-indazol-5-yl)methanamine and 4-bromo-2-ethylbenzene-1-sulfonyl chloride.
Sources & evidence
- ORD record
- ord-677b436098f542438ac981de2d1ce9c0
- Source dataset
- uspto-grants-2014_09
- Patent number